Jacky Luiten

138 | Chapter 9 20. Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith ‐ Bindman R, et al. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst. 2010;102(14):1040 ‐ 1051. 21. van Breest Smallenburg V, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, van Beek M, et al. Lower sensitivity of screening mammography after previous benign breast surgery. Int J Cancer. 2012;130(1):122 ‐ 128. 22. Elshof LE, Tryfonidis K, Slaets L, van Leeuwen ‐ Stok AE, Skinner VP, Dif N, et al. Feasibility of a prospective, randomised, open ‐ label, international multicentre, phase III, non ‐ inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ ‐ The LORD study. Eur J Cancer. 2015;51(12):1497 ‐ 1510. 23. Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, et al. Addressing overtreatment of screen ‐ detected DCIS; the LORIS trial. Eur J Cancer. 2015;51(16):2296 ‐ 2303. 24. Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485 ‐ 492. 25. Benveniste AP, Ortiz ‐ Perez T, Ebuoma LO, Sepulveda KA, Severs FJ, Roark A, et al. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)? Eur J Radiol. 2017;96:74 ‐ 79. 26. Furman ‐ Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer. 2005;104(4):708 ‐ 718. 27. Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat. 1988;11(3):241 ‐ 248. 28. Hieken TJ, Farolan M, D'Alessandro S, Velasco JM. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers. Surgery. 2001;130(4):593 ‐ 600; discussion 600 ‐ 591. 29. Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N. Meta ‐ analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg. 2015;102(8):883 ‐ 893. 30. Yoon GY, Choi WJ, Kim HH, Cha JH, Shin HJ, Chae EY. Surgical Outcomes for Ductal Carcinoma in Situ: Impact of Preoperative MRI. Radiology. 2020;295(2):296 ‐ 303. 31. Szynglarewicz B, Kasprzak P, Biecek P, Halon A, Matkowski R. Screen ‐ detected ductal carcinoma in situ found on stereotactic vacuum ‐ assisted biopsy of suspicious microcalcifications without mass: radiological ‐ histological correlation. Radiology and oncology. 2016;50(2):145 ‐ 152. 32. Ahmed M, Rubio IT, Klaase JM, Douek M. Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat Rev Clin Oncol. 2015;12(11):645 ‐ 663. 33. Tardioli S, Ballesio L, Gigli S, F DIP, D'Orazi V, Giraldi G, et al. Wire ‐ guided Localization in Non ‐ palpable Breast Cancer: Results from Monocentric Experience. Anticancer Res. 2016;36(5):2423 ‐ 2427. 34. Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non ‐ palpable breast cancers: a meta ‐ analysis. J Surg Oncol. 2012;105(8):852 ‐ 858. 35. Luini A, Zurrida S, Paganelli G, Galimberti V, Sacchini V, Monti S, et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg. 1999;86(4):522 ‐ 525. 36. Gray RJ, Salud C, Nguyen K, Dauway E, Friedland J, Berman C, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8(9):711 ‐ 715. 37. Gobardhan PD, de Wall LL, van der Laan L, ten Tije AJ, van der Meer DC, Tetteroo E, et al. The role of radioactive iodine ‐ 125 seed localization in breast ‐ conserving therapy following neoadjuvant chemotherapy. Ann Oncol. 2013;24(3):668 ‐ 673. 38. Postma EL, Verkooijen HM, van Esser S, Hobbelink MG, van der Schelling GP, Koelemij R, et al. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire ‐ guided localisation' (WGL) in breast conserving surgery for non ‐ palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat. 2012;136(2):469 ‐ 478.